Xiangyang Li, MD, PHD
Psychiatry Physician in Milford, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
Xiangyang Li, MD, PHD filed 5,751 Medicare Part D claims in 2023 as a Psychiatry Physician in Milford, Massachusetts, prescribing 84% generic.
- 6K
- Part D claims, 2023
- 84%
- generic prescribing
- $19.4K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
Xiangyang Li, MD, PHD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
5,751 Top 5% higher than 95% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Xiangyang Li, MD, PHD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Xiangyang Li, MD, PHD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Massachusetts
How Psychiatry Physician compares to other specialties among Massachusetts providers
Psychiatry Physician share within Massachusetts
Psychiatry Physician is one of the more visible NUCC categories in Massachusetts
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Psychiatry Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Psychiatry Physician ABMS/AOA estimate
Est. board-certified rate (Psychiatry Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Psychiatry Physician US NPIs
Specialty board-certified rate — Psychiatry Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Xiangyang Li, MD, PHD appears in the CMS NPPES registry as a Psychiatry Physician provider holding MD, PHD credentials at 229 EAST MAIN ST SUIT #204, Milford, MA, 01757, with a listed phone of (508) 458-9060. NPI 1497719132 was issued on 04/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Li most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 5,751 prescription claims written by this provider, covering 219 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 16% brand-name and 84% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Psychiatry Physician is a high-volume specialty nationwide, with 53,104 enrolled providers across 56 states and an average of 1,038 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1497719132 |
|---|---|
| Specialty | Psychiatry Physician |
| Credentials | MD, PHD |
| Gender | Male |
| NPI Issued | 04/12/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Xiangyang Li, MD, PHD's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Xiangyang Li, MD, PHD. Source: openpaymentsdata.cms.gov.
Total received
$19.4K
Largest payer
Neurocrine Biosciences, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Massachusetts BORIM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to Xiangyang Li, MD, PHD. To verify Xiangyang Li, MD, PHD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
16% brand-name claims vs 84% generic, on 5,751 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 7,277
- Total Day Supply
- 200,964
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $1.2M
- Generic Drug Cost
- $160K
Patient Demographics
- Average Patient Age
- 62.1 years
- Avg HCC Risk Score
- 1.29
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 103, 65-74: 76, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Xiangyang Li, MD, PHD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Spravato
Spravato
328 claims
- Quetiapine Fumarate
Quetiapine Fumarate
294 claims
- Clonazepam
Clonazepam
229 claims
- Alprazolam
Alprazolam
227 claims
- Buspirone Hcl
Buspirone Hcl
217 claims
- Mirtazapine
Mirtazapine
206 claims
- Lorazepam
Lorazepam
195 claims
- Gabapentin
Gabapentin
177 claims
| Drug | Claims |
|---|---|
| Spravato Esketamine Hcl | 328 |
| Quetiapine Fumarate | 294 |
| Clonazepam | 229 |
| Alprazolam | 227 |
| Buspirone Hcl | 217 |
| Mirtazapine | 206 |
| Lorazepam | 195 |
| Gabapentin | 177 |
| Lamotrigine | 176 |
| Trazodone Hcl | 176 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Psychiatry Physician Overview
How Xiangyang Li, MD, PHD fits within the Psychiatry Physician landscape nationally.
Xiangyang Li, MD, PHD's 5,751 claims are above the specialty average of 1,038.
Nearby Psychiatry Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Li.
Compare Psychiatry Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Massachusetts medical board — federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Psychiatry Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Massachusetts
Frequently Asked Questions
What is Xiangyang Li, MD, PHD's specialty? ▼
How much does Xiangyang Li, MD, PHD prescribe under Medicare Part D? ▼
Where is Xiangyang Li, MD, PHD located? ▼
What is Xiangyang Li, MD, PHD's NPI number? ▼
Does Xiangyang Li, MD, PHD prescribe more brand-name or generic drugs? ▼
How many Psychiatry Physician providers are there in the US? ▼
What drugs does Xiangyang Li, MD, PHD prescribe most often? ▼
Does Xiangyang Li, MD, PHD accept Medicare? ▼
How can I verify Xiangyang Li, MD, PHD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology